Open original FDA record ↗Recall record
- FDA identifier
- Z-0954-2021
- Company in FDA record
- Becton Dickinson & Co.
- FDA record creation date
- Feb 5, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Some N1 and N2 master mix pouches packaged within the lots of BioGX SARS-CoV-2 Reagents for BD MAX System may be mislabeled. This could result in a kit containing two pouches of N1 master mix or two pouches of N2 master mix, instead of one pouch of each. If laboratory personnel do not notice that both pouches contain tubes with the same color foil seal and use two of the same tubes, there is a low potential for a false negative SARS-CoV-2 result. A false negative SARS-CoV-2 result could lead to an increased risk of disease progression for the patient and additional spread of SARS-CoV-2 if the patient is not quarantined.
Source facts
- Action
- On January 12, 2021, BD issued an Urgent Device Correction notice to customers via letters with FedEx tracking. A customer response form is included with the letter that the customer is instructed to complete electronically, email or fax back to BD. Returned response forms will be reconciled with the customer list.
- Initiated
- 2021-01-07
- Root cause
- Process control
- Terminated
- 2021-12-03
- Distribution
- US nationwide distribution.
- Recall number
- Z-0954-2021
- Recall status
- Terminated
- CDRH record ID
- 185489
- FDA record created
- 2021-02-05
- Recall event number
- 87178